Jay Olson's
Stock Forecasts
11.11%
4/36 win trades
Price targets by Jay Olson
| Company name & ticker | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|
 Terns Pharmaceuticals, Inc. TERN | 10 months ago | $20 216.95% upside | $6.36 | StreetInsider | Previous targets (0) |
 Voyager Therapeutics, Inc. VYGR | 11 months ago | $18 408.47% upside | $6.92 | StreetInsider | Previous targets (0) |
 Intellia Therapeutics, Inc. NTLA | 11 months ago | $60 485.36% upside | $17.16 | StreetInsider | Previous targets (0) |
 CRISPR Therapeutics AG CRSP | 11 months ago | $95 76.07% upside | $49.51 | StreetInsider | Previous targets (0) |
 Biogen Inc. BIIB | 11 months ago | $255 83.78% upside | $181.18 | StreetInsider | |
 Incyte Corporation INCY | 11 months ago | $82 -4.04% downside | $73.6 | TheFly | |
 Revolution Medicines, Inc. RVMD | 11 months ago | $60 64.20% upside | $46.83 | StreetInsider | |
 Bicycle Therapeutics plc BCYC | 11 months ago | $48 570.39% upside | $25.32 | StreetInsider | Previous targets (0) |
 Neurocrine Biosciences, Inc. NBIX | 11 months ago | $192 44.56% upside | $116.57 | StreetInsider | |
 Galecto, Inc. GLTO | 11 months ago | $10 200.30% upside | $6.71 | StreetInsider | Previous targets (0) |
 Q32 Bio Inc. QTTB | 11 months ago | $80 4295.60% upside | $48.47 | StreetInsider | |
 Skye Bioscience, Inc. SKYE | over 1 year ago | $21 546.15% upside | $9.98 | StreetInsider | |
 Amgen Inc. AMGN | over 1 year ago | $380 27.77% upside | $312.32 | StreetInsider | Previous targets (0) |
 Sage Therapeutics, Inc. SAGE | over 1 year ago | $17 95.62% upside | $12.57 | StreetInsider | Previous targets (0) |
 Sutro Biopharma, Inc. STRO | over 1 year ago | $10 1061.44% upside | $5.09 | StreetInsider | Previous targets (0) |
 Marinus Pharmaceuticals, Inc. MRNS | over 1 year ago | $9 1537.10% upside | $9.04 | StreetInsider | Previous targets (0) |
 Viking Therapeutics, Inc. VKTX | over 1 year ago | $138 465.57% upside | $80.83 | StreetInsider | Previous targets (0) |
 ACADIA Pharmaceuticals Inc. ACAD | over 1 year ago | $19 -23.90% downside | $19.98 | StreetInsider | Previous targets (0) |
 Procaps Group S.A. PROC | almost 2 years ago | $10 890.09% upside | $3.25 | Benzinga | Previous targets (0) |
Other analysts covering same stocks
Daniel Busby
RBC Capital
100%
win rate
Steve Chesney
Atlantic Equities
60%
win rate
Olivia Brayer
Cantor Fitzgerald
60%
win rate
Charles Duncan
Cantor Fitzgerald
40%
win rate